These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30612334)

  • 41. Phenotypic Heterogeneity of Variably Protease-Sensitive Prionopathy: A Report of Three Cases Carrying Different Genotypes at
    Baiardi S; Mammana A; Rossi M; Ladogana A; Carlà B; Gambetti P; Capellari S; Parchi P
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.
    Baiardi S; Rossi M; Mammana A; Appleby BS; Barria MA; Calì I; Gambetti P; Gelpi E; Giese A; Ghetti B; Herms J; Ladogana A; Mikol J; Pal S; Ritchie DL; Ruf V; Windl O; Capellari S; Parchi P
    Acta Neuropathol; 2021 Oct; 142(4):707-728. PubMed ID: 34324063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.
    Head MW; Yull HM; Ritchie DL; Langeveld JP; Fletcher NA; Knight RS; Ironside JW
    Brain; 2013 Apr; 136(Pt 4):1102-15. PubMed ID: 23550113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
    Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
    Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.
    Moudjou M; Chapuis J; Mekrouti M; Reine F; Herzog L; Sibille P; Laude H; Vilette D; Andréoletti O; Rezaei H; Dron M; Béringue V
    Sci Rep; 2016 Jul; 6():29116. PubMed ID: 27384922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate.
    Kim C; Haldiman T; Cohen Y; Chen W; Blevins J; Sy MS; Cohen M; Safar JG
    PLoS Pathog; 2011 Sep; 7(9):e1002242. PubMed ID: 21931554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cerebral cortex swelling in V180I genetic Creutzfeldt-Jakob disease: comparative imaging study between sporadic and V180I genetic Creutzfeldt-Jakob disease in the early stage.
    Muroga Y; Sugiyama A; Mukai H; Hashiba J; Yokota H; Satoh K; Kitamoto T; Wang J; Ito S; Kuwabara S
    Prion; 2023 Dec; 17(1):105-110. PubMed ID: 37013454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.
    Rubenstein R; Chang B
    PLoS One; 2013; 8(7):e66352. PubMed ID: 23843953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RT-QuIC as ultrasensitive method for prion detection.
    Atarashi R
    Cell Tissue Res; 2023 Apr; 392(1):295-300. PubMed ID: 35084571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.
    Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correction to: In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrP
    Wang Z; Yuan J; Shen P; Abskharon R; Lang Y; Dang J; Adornato A; Xu L; Chen J; Feng J; Moudjou M; Kitamoto T; Lee HG; Kim YS; Langeveld J; Appleby B; Ma J; Kong Q; Petersen RB; Zou WQ; Cui L
    Mol Neurobiol; 2019 Aug; 56(8):5470. PubMed ID: 30707392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene.
    Qina T; Sanjo N; Hizume M; Higuma M; Tomita M; Atarashi R; Satoh K; Nozaki I; Hamaguchi T; Nakamura Y; Kobayashi A; Kitamoto T; Murayama S; Murai H; Yamada M; Mizusawa H
    BMJ Open; 2014 May; 4(5):e004968. PubMed ID: 24838726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Cu
    Sakaguchi Y; Nakamura R; Konishi M; Hatakawa Y; Toyoda H; Akizawa T
    Biochem Biophys Res Commun; 2019 Jun; 514(3):798-802. PubMed ID: 31079927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variant CJD. 18 years of research and surveillance.
    Diack AB; Head MW; McCutcheon S; Boyle A; Knight R; Ironside JW; Manson JC; Will RG
    Prion; 2014; 8(4):286-95. PubMed ID: 25495404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.